Futura Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Futura Medical generated cash of $570,253, which is more than the previous year. Cash used in financing activities reached the amount of $4,549,868 last year. Net change in cash is therefore $3,688,070.
Cash Flow
| 2014 | -3.06M | 13.05K | 11.55M |
|---|---|---|---|
| 2015 | -5.36M | 35.61K | 24.75K |
| 2016 | -3.29M | 22.17K | 11.44M |
| 2017 | -4.17M | -36.27K | 220.75K |
| 2018 | -4.70M | 23.06K | 5.48M |
| 2019 | -6.65M | -10.45K | 19.28K |
| 2020 | -4.54M | -7.44K | 3.05M |
| 2021 | -3.87M | -419.72K | 13.64M |
| 2022 | -5.77M | -740.69K | 169.58K |
| 2023 | 570.25K | -1.43M | 4.54M |
FUM.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.02M | 10.37M | 1.01M | 2.51M | 9.15M | 8.36M | 12.35M | 4.18M | 9.49M | 990.56K |
Operating activities | ||||||||||
Net income | -6.89M | -6.87M | -5.86M | -2.92M | -11.14M | -7.23M | -4.83M | -4.53M | -6.07M | -3.47M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 130.27K | 24.73K | 19.80K | 25.00K | 20.70K | 19.85K | 13.42K | 6.24K | 6.95K | 4.52K |
Stock-based compensation expense | 2.72M | 671.85K | 181.82K | 149.36K | 101.40K | 0 | 201.26K | 54.40K | 121.11K | 177.04K |
| Deferred income tax benefit | 2.72M | 671.85K | 181.82K | 149.36K | 101.40K | 0 | 201.26K | 54.40K | 121.11K | 177.04K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -974.49K | -186.42K | -39.46K | 61.40K | 204.92K | -125.33K | -42.08K | 16.98K | 45.21K | 0 |
Inventories | -339 | 0 | 0 | 7.78K | 0 | 62.63K | 13.22K | 80.12K | -22.25K | -106.51K |
Accounts payable | 0 | -325.07K | 1.31M | -4.08M | 2.82M | 1.52M | -356.03K | 101.28K | 121.23K | 0 |
Cash generated by operating activities | 570.25K | -5.77M | -3.87M | -4.54M | -6.65M | -4.70M | -4.17M | -3.29M | -5.36M | -3.06M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.50M | -740.69K | -419.72K | -8.37K | -32.73K | -4.51K | -55.59K | -7.48K | -15.95K | -7.79K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.43M | -740.69K | -419.72K | -7.44K | -10.45K | 23.06K | -36.27K | 22.17K | 35.61K | 13.05K |
Financing activities | ||||||||||
Common Stock Issued | 4.54M | 169.58K | 14.31M | 3.27M | 19.28K | 5.94M | 220.75K | 12M | 24.75K | 12.09M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 4.54M | 169.58K | 13.64M | 3.05M | 19.28K | 5.48M | 220.75K | 11.44M | 24.75K | 11.55M |
Net Change In Cash | 3.68M | -6.34M | 9.35M | -1.49M | -6.64M | 795.27K | -3.99M | 8.16M | -5.30M | 8.50M |
Cash at end of period | 7.71M | 4.02M | 10.37M | 1.01M | 2.51M | 9.15M | 8.36M | 12.35M | 4.18M | 9.49M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |